Learn More-External Link
Trending at Lumira Ventures
KAI to Present KAI-9803 Phase I/II Trial Data in a Late-Breaking Session of the ACC
Learn More-External Link
MAKO Surgical Corp. Closes $30 Million in Series C Funding
(FORT LAUDERDALE, FL) — MAKO Surgical Corp., an emerging orthopedic medical device company developing advanced solutions for least invasive knee surgery, announced today that it has closed on a $30 million Series C private equity financing led by funds affiliated …
Alveolus, Inc. Launches AERO™ Hybrid Tracheobronchial Stent System in U.S.
Learn More-External Link
Ception Therapeutics Raises $63 Million in Series C Financing.
MALVERN, PA – January 29, 2007 – Ception Therapeutics, Inc., an emerging biopharmaceutical company discovering and developing novel biologic and small-molecule agents to address unmet medical needs, today announced that it has raised $63 million through a Series C private …
Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
CAMBRIDGE, Mass., Jan. 9 — Archemix Corp. today announced that it has signed an agreement with Pfizer focused on the discovery of first-in-class aptamers for the development and commercialization as therapeutics.As part of the collaboration, Archemix will use its proprietary …